Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248816 · ClinicalTrials.gov registry record · NA
Hepatocellular Carcinoma Surveillance in Cirrhotics
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 615
- Enrollment target
NCT04248816: Completed NA study, sponsored by University of Pennsylvania.
NCT04248816 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 615 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04248816, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 615 participants
- Enrollment target
Study Summary
This is a 3-arm pilot randomized controlled trial applying behavioral economic approaches (opt-out framing and financial incentives) to encourage patients with liver cirrhosis to complete regular surveillance ultrasounds which may allow for earlier diagnosis of and better outcomes for hepatocellular carcinoma (HCC).
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL Opt-out
- BEHAVIORAL Opt-out + Incentive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2022-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04248816
The ClinicalTrials.gov registry entry for NCT04248816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 615 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT04248816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04248816 about?
NCT04248816 is a clinical study titled "Hepatocellular Carcinoma Surveillance in Cirrhotics". This is a 3-arm pilot randomized controlled trial applying behavioral economic approaches (opt-out framing and financial incentives) to encourage patients with liver cirrhosis to complete regular surveillance ultrasounds which may allow for earlier diagnosis of and better outcomes for hepatocellular...
What is the current status of trial NCT04248816?
This trial is currently completed. It is a NA study. The enrollment target is 615 participants. The study started on 2020-11-19. Estimated completion is 2022-02-14.
What interventions are being tested in trial NCT04248816?
The interventions under investigation include: Usual care (BEHAVIORAL), Opt-out (BEHAVIORAL), Opt-out + Incentive (BEHAVIORAL).
Who is sponsoring clinical trial NCT04248816?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.